IndiaTickerLatest filing: Press Release - RPG Life Sciences Limited
ObservedCompany dossier
RPG Life Sciences
NSE:RPGLIFE · ISIN INE105J01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
RPG Life Sciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹172.7 Cr · PAT ₹34.9 Cr.
Exchange XBRLLatest ownership: promoter group 72.95% and public 27.05% as of 30 Jun 2026.
Exchange XBRLLatest rating action: RPG Life Sciences Limited: Ratings reaffirmed
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Press Release - RPG Life Sciences Limited
NSE · exchange filing
Observed
Source filing General Updates - RPG Life Sciences Limited
NSE · exchange filing
Observed
Source filing Other Restructuring - RPG Life Sciences Limited
NSE · exchange filing
Observed
Source filing General Updates - RPG Life Sciences Limited
NSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹172.7 Cr
- Profit after tax
- ₹34.9 Cr
- EPS
- ₹21.12
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.95%
- Public
- 27.05%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL